Legendary Inv. Share Discussion Threads

[chinese investor] 13/7/2018 14:11

Good Points Belt !
Good Answers Soup !

[soupdragon55] 13/7/2018 13:57

Belt,

1 - Has LEG ever achieved a profitable exit in its 20 year history? If not, can we trust Zaf to achieve it now?

2 - LEG bought VS shares at 2 prices, the most recent being after the £66m valuation. Overall they have paid £702k for their share.

3 - Zaf's career background - Was at Saloman Bros. for one year as a graduate so has no bearing on anything. Most other employment was in 1 year stints. Rothschild part of mergers team has some benefit but he's never had experience of growing companies.

4 - NAV as a figure has increased, but the dilution has countered that gain. £6m NAV is only 0.16p shareprice. Investment companies typically trade at discount to NAV.

5 - If placing was oversubscribed, why did Zaf take nearly 20%? In essence we have all been diluted for no other reason than Zaf wanted shares at a discount to the prevailing price? Why didn't he issue fewer shares and buy his in the open market? That would have shown greater faith in the company.

6 - See my previous post, Schlumberger who did the analysis on the previous drill stated that no reserves were estimated since the logging equipment was lost.
Also Dunraven will need to finance and farm out, diluting LEG.

7 - Virtualstock announced they intended to list within 18 months previously, that was 12 months ago. Personally I don't see why they would target NASDAQ listing. This isn't the nineties dotcom era.


In summary, same old questions, no new answers.

[kemorkid] 13/7/2018 13:51

Excellent synopsis belt
Well done snd thanks

[belt n braces] 13/7/2018 13:09

Key points from Zaf's interview with Proactive:

(1) Overall objective of LEG is to buy companies that eventually lead to a trade sale or listing.

(2) In regards to return on investment, he noted the original investment in Virtualstock and the fact that last year a VC bought in at a valuation of £ 66m, which was a massive increase on Leg's original investment . Since that buy-in, Virtualstock has continued make progress. Overall this has been a massive success.

(3)Zaf's own career is that he started with Solomon Brothers and then moved to Rothchild. However, his motivation was to be a principal rather than an adviser, hence the eventual move to LEG.

(4)LEG's share price is basically the same as it was in 2015, even though the NAV at that time was less than half of where we are today (the NAV now being £ 6M).

(5) The recent placing was oversubscribed by a significant amount, and more than what was originally required was taken up. This also included a £100K amount from Zaf himself, which he viewed as being a vote of confidence in the company.

(6) He noted Dunraven, which was moving quite fast and could be listing quite soon. The potential there was massive (with proven reserves).

(7) In regards to virtualstock, he noted the potential plan to list on the Nasdaq within 18 to 24 months.


So in summing up, and

in my view, a very strong buy at today's price

[belt n braces] 13/7/2018 13:08

Key points from Zaf's interview with Proactive:

(1) Overall objective of LEG is to buy companies that eventually lead to a trade sale or listing.

(2) In regards to return on investment, he noted the original investment in Virtualstock and the fact that last year a VC bought in at a valuation of £ 66m, which was a massive increase on Leg's original investment . Since that buy-in, Virtualstock has continued make progress. Overall this has been a massive success.

(3)Zaf's own career is that he started with Solomon Brothers and then moved to Rothchild. However, his motivation was to be a principal rather than an adviser, hence the eventual move to LEG.

(4)LEG's share price is basically the same as it was in 2015, even though the NAV at that time was less than half of where we are today (the NAV now being £ 6M).

(5) The recent placing was oversubscribed by a significant amount, and more than what was originally required was taken up. This also included a £100K amount from Zaf himself, which he viewed as being a vote of confidence in the company.

(6) He noted Dunraven, which was moving quite fast and could be listing quite soon. The potential there was massive (with proven reserves).

(7) In regards to virtualstock, he noted the potential plan to list on the Nasdaq within 18 to 24 months.


So in summing up, and

in my view, a very strong buy at today's price

[chinese investor] 13/7/2018 11:58

Unbelievably this is twelve months old.....

Professor Pettigrew (LEG) 20 Jul 2017 - 13:26:20
This is actually DYNAMITE news.
VS (and LEG) will ensure that Virtualstock has maximum value before floating on Nasdaq.
We really could be looking at a 1p valuation for LEG now by this time next year.
And you can still pick them up at 0.14p.
Unbelievable.

[professor pettigrew] 13/7/2018 11:40

Cheers livup - Zaf is doing a pretty decent job now with some well earned publicity for LEG.

I'd like to see him, and someone from VS on Bloomberg and CNBC though, that really would get things moving here.

That may come when VS get much bigger and plan their IPO on NASDAQ within the next 18 months or so.

I think plans for our 1p party will start to be laid down around next August.

[livup967] 13/7/2018 11:27

nice one P/P I post it just before seen your post but it's on here again...
encase some one else never see it...


REGARDS

[livup967] 13/7/2018 11:22

P/P here is the link....




REGARDS speak soon... keep up the good work....

[professor pettigrew] 13/7/2018 11:21

Morning livup - yup saw it earlier. paulthomas103 posted the link on here this morning.

An excellent interview - LEG are certainly going places. It will all take time, but the underlying strength is there now for a sizeable re-rate going forward.

[livup967] 13/7/2018 11:11

morning P/P just to let you know....

ZAF HAS GOT A NEW VIDEO INTERVIEW ON PRO ACT INVESTORS TUNE IN WHEN YOU CAN...


REGARDS

[professor pettigrew] 13/7/2018 10:23

Take a read: CryptoPolice Token Sale Now Live on Crowd for Angels (NewsBTC): www.newsbtc.com/press-r

[professor pettigrew] 13/7/2018 10:20

Hi paul - yes, I must admit I was a bit surprised to hear him focus in on Dunraven.

Mind, it's refreshing to know, and as we are already knowledgeable on VS and its future prospects, it shows what a diverse spread of investments LEG have.

Seems to me, listening to it, that Dunraven could actually IPO in pretty short order.

Very exciting times ahead here.

[paulthomas103] 13/7/2018 10:12

Thanks guys, he’s all over it and it’s good to see as I have no doubt about his analytical skills. He really rates Dunraven then.

[professor pettigrew] 13/7/2018 09:56

Yes, after a long time when only a few of us appreciated the potential of LEG, Zaf now seems to be getting out a bit more and spreading the word.

Message remains the same as always:-

Continue to accumulate and hold very tight.

[belt n braces] 13/7/2018 09:53

Paul, excellent find.

I think that is the best interview that I have heard so far from Zaf. As he said, he recently put in 100 hundred grand of his own cash, and he now seems to be actively promoting the company. The message is that the market has undervalued this company. So all good.

[kemorkid] 13/7/2018 09:48

A must listen to for all investors
Excellent find
Thanks Paul

[chinese investor] 13/7/2018 08:46

Announcement to be made at Quarry House, Leeds at 10 am.

#quarryamazon #amazonleeds #10am #roombooked #teaandbiscuits

[professor pettigrew] 13/7/2018 08:26

NHS seeks the Amazon appeal with Virtualstock expansion

Sheffield Teaching Hospitals NHS Foundation Trust has implemented Virtualstock’s digital procurement platform, which aims to bring Amazon-like simplicity to the NHS’s supply chain.

Called the Edge, Virtualstock’s solution is an end-to-end ‘PIM2Pay’; product catalogue comprising everything from product information management (PIM) to payment via electronic invoice.

Six of the top 12 online UK retailers, including Sainsbury’s, Argos, Tesco and John Lewis, use Virtualstock’s internal marketplace. The platform used within the NHS is a repurposed version of The Edge, appropriately named The Edge for Health.

Described as similar to Amazon, the technology hosts a marketplace of products and services for the NHS, ranging from everyday commodities to medical equipment, computer systems and cleaning contracts.

The Edge has been designed to meet retail and GS1 e-commerce standards and was adopted into the NHS as part of Lord Carter’s ambitions to save the NHS £22bn from its procurement and purchasing by 2020.

Guy’s and St Thomas’ is Virtualstock’s longest-standing NHS client, which has been using its digital marketplace since November 2015.

Sheffield Teaching Hospitals is the latest trust in the Shelford Group to sign up to the platform. Andrea Smith, the trust’s director of procurement, said: “With the NHS procurement landscape changing significantly, we needed to implement a truly innovative solution and Virtualstock was the obvious choice.

“We are currently working with our suppliers to ensure the product catalogue is enriched and price files authorised. That process will inevitably lead to more accurate orders and less invoice queries. It is also a great way for us to see the vast product ranges that historically we did not have room to store on our legacy system.”

The Shelford Group, a collection of trusts comprised of leading multi-specialty healthcare organisations, is in the middle of its roll-out programme with Virtualstock. The UK-based software as a service (SaaS) company also has a strategic partnership in place with NHS Shared Business Services.

Speaking to Digital Health News, Rob Knott, director of healthcare and public sector at Virtualstock, said the platform plugged a long-standing hole in the way the NHS ordered goods and services – namely, by bridging the flow of data from a supplier’s catalogue to a hospital’s inventory. “Procurement and supply chain management has been dramatically underfunded for many years,” said Knott.

“The Department of Health has never designed and developed a world-class model to support hospitals. Hospitals have never recognised the importance and significance of owning a world-class supply chain function and therefore, have never invested in one.”

The majority of the NHS still orders much of its products through legacy systems like Oracle, which lacks product images and contains little in the way of product information. “It’s a hideously static environment,” explained Knott.

According to Virtualstock, Tesco has managed to shave its waste down to around one percent through its use of The Edge. The NHS has since acknowledged the supermarket giant’s success story and been working with Virtualstock to assess how its technology can be used for its own purposes.

The Amazon effect

“There’s levels of sophistication in retail, a massive focus that’s been around data accuracy on products,” explained Knott. “I started to think, rather than replicating this technology, why not lift it and shift it from retail into healthcare?”

Additionally, Knott said a lack of transparency in the NHS’s procurement process made it difficult to keep track of what had been ordered, when and by whom. “There are so many products that go into obsolescence or go to waste because they’re bought in massive quantities and stockpiled in hospitals and forgotten about.

“Imagine in a big teaching hospital where there are 3,000 or so people requisitioning something every day. Before they order something, they have to go through several tiers of authority.

“There is an alignment to the consumerism of the purchasing life-cycle that our platform seeks to maintain in healthcare. But it’s also configured so that if there are any products that need to be authorised before it gets ordered, it can go through the workflow with complete transparency and visibility.”

According to Knott, in one UK hospital in 2012, £800,000 of expired products were found across wards. This included around £40,000 of orthodontics products that had been purchased seven years beforehand.

“Some of the most advanced hospitals – which at least have systems to track waste – believe that around 10-12% of what they purchase goes to waste. Interestingly, the Department of Health identified that hospitals were purchasing drugs twice per day, yet they had several weeks’ worth of stock of the same drugs on the hospital shelves.”

The consumerism of procurement – something Knott refers to as “the Amazon effect” – suggests that organisations are eager simplify their procurement processes by adopting new technologies into their supply chains. For the NHS, this could mean knocking a considerable sum off its waste bill and delivering measurable cost-savings as a result.

But in achieving Lord Carter’s targeted £5bn per year between now and 2020, Knott suggested The Edge was just part of the jigsaw. “It’s an enabler. We can only configure the technology to support what a trust ultimately wants to do.”

[professor pettigrew] 13/7/2018 08:20

We didn't hear from you yesterday, I was hoping you'd died.

[chinese investor] 13/7/2018 08:13

NHS to make an announcement on Monday 16 July 2018 saying they are ditching all other procurement software and the are going to use AMAZON exclusively.

#nhsamazon #amazon-nhs